Josiane Otto
Papers
1
Total Citations
17
H-Index
1
About
Josiane Otto is a leading figure in radiation oncology, with a focused expertise in stereotactic body radiotherapy (SBRT) and its application to lung cancer. Her major contributions center on the early toxicity and preliminary outcomes of CyberKnife® treatments, a non-invasive, high-precision radiation technique. Her seminal 2008 paper, "Analyse de la toxicité précoce des traitements par Cyberknife® des cancers pulmonaires et résultats préliminaires," has garnered 17 citations, establishing a foundational understanding of the safety and efficacy of this approach. This work was pivotal in demonstrating that CyberKnife could deliver ablative doses to lung tumors while minimizing damage to surrounding healthy tissue, a critical advancement for patients with inoperable or early-stage disease. Otto’s research has directly influenced clinical protocols, helping to refine dose constraints and patient selection criteria. Her rigorous analysis of early toxicities—such as radiation pneumonitis and chest wall pain—has provided essential guidelines for practitioners worldwide. Through her dedicated investigation of SBRT, Josiane Otto has significantly improved the therapeutic ratio for lung cancer patients, cementing her reputation as a key contributor to modern, precise oncological care.
Research Focus
Key Achievements
Top Papers
- 1